Dragonfly OpStar™ 1014651
Dragonfly OpStar 1014651 is a medical device (FDA Class II; FDA product code DQO, Catheter, Intravascular, Diagnostic) made by Lightlab Imaging, Inc., listed in FDA GUDID since 17 Dec 2019 (UDI-DI 05415067031129), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05415067031129 | Date17 Dec 2019 | StatusListed |
Official records
- AccessGUDID record 05415067031129
From the FDA record
- Device description
- Imaging Catheter
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Dragonfly OpStar™
- Generic name
- Coronary optical coherence tomography system catheter
- Model / Ref / Catalog
- 1014651
- Primary DI / UDI-DI
- 05415067031129
- FDA product code
- DQO
- GMDN term
- Coronary optical coherence tomography system catheter
- Device class
- Class II
- Regulation number
- 870.1200
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code DQO (CATHETER, INTRAVASCULAR, DIAGNOSTIC).
- Performa® 00884450003213 7601-33/B by Merit Medical Systems, Inc.
- Performa® 00884450002728 7602-81/B by Merit Medical Systems, Inc.
- MICRUS MICROCATHETER, COURIER FLEX, MODEL MSF 170000-00 by Micrus Endovascular Corporation
- ACUSON X300 DIAGNOSTIC ULTRASOUND SYSTEM by SIEMENS MEDICAL SOLUTIONS USA, INC.
- ASC HIGH PRESSURE BRAIDED TUBES by Adam Spencer Corp.
- BLOOD PRESSURE MEASUREMENT SYSTEM(DSPM-70) by Data Sciences Intl., Inc.
- MEADOX SURGIMED GUIDE CATHETER by Meadox Surgimed, Inc.
- CATHETER, CAVA (CAVAFIX) by B. Braun Instruments
- 7FR. AND 8FR. TRIGUIDE GUIDING CATHETER ADD. CURVE by Scimed
- DIAGNOSTIC INTRAVASCULAR CATHETER by Target Therapeutics